Zhou Xiao looked at a pile of email replies from academic journals and was quite depressed.
Western academic circles will not regard exploratory experiments without laboratories (the qualification of origin science and technology biomedical laboratory has not been completed) and without basic scientific basis as real biomedical experiments, but as novels or even jokes.
The western academic community is completely impassable. It is extremely difficult for Xia Guo's professional laboratories to publish academic papers in professional journals such as cell and nature, let alone the origin technology without laboratory qualification.
The academic road will not work, and the medical clinical trial will not work.
Zhou Xiao can't find a passer-by at will and drag him to the laboratory for experiment!
Moreover, even if there are patients who are willing to accept the treatment of symbiotic green leaf protein, Zhou Xiao does not dare to do it easily.
When it comes to clinical trials or clinical treatment, if it does not comply with relevant laws and norms, even if it succeeds in the future, Zhou Xiaohe origin technology will face a lot of legal and moral risks.
In addition, if clinical trials cannot be conducted, Zhou Xiao will not be able to obtain any monopoly value or aversion value, and the system will be stuck in this scientific and technological product, which is equal to waste.
Passive waiting has never been Zhou Xiao's personality. Zhou Xiao is ready to go back to his alma mater Jiangcheng University of technology and ask his mentor Liao Hai for help.
A few years ago, although the clear boundary of one or two schools was cancelled, Jiangcheng University of technology is still the level of two schools, which is more than one grade worse than 211 and 985 Jiangcheng University.
What's worse is that the school of life engineering of Jiangcheng University of technology is still connected with major well-known biomedical academic journals in China. Shouldn't it be a problem to ask the school to help send a paper?
Xia state is a human society, which is also true academically.
If your paper is true and effective, it will be easier to publish it with the help of acquaintances.
After the paper was published and received some discussion in the academic community, Zhou Xiao had the opportunity to cooperate with the hospital to apply for the indicators of clinical trials.
This time, Zhou Xiao returned to his alma mater not empty handed, but with full sincerity - donated a million grants to the College of bioengineering to help students with poor families and excellent academic achievements.
Liao Hai, Zhou Xiao's tutor when he was a graduate student and now the vice president of the college, met Zhou Xiao at the school.
When he saw Zhou Xiao supporting one million grants in the name of origin technology, a smile piled up on his face.
The origin of technology and safety mask was created by Zhou Xiao.
In addition to being shocked, Zhou Xiao's name immediately appeared in the well-known alumni record of Jiangcheng University of technology.
Zhou Xiao directly entered the topic and hoped to publish his papers in domestic biomedical related formal journals.
"This is simple!" Liao Hai said, "as long as there is no problem with the copyright of the paper, I can contact some journals to help publish it. What do you think of Bioscience?" Liao Hai thought that Zhou Xiaoshi needed to publish several papers because of the company's qualification evaluation, so he agreed.
Bioscience is a cooperative Academic Journal of the school of bioengineering of Jiangcheng University of technology, and the influencing factors are also OK.
However, when Zhou Xiao handed the prepared paper to Liao Hai, as the vice president of the College of bioengineering, Liao haileng thought he could still see a lot from the paper.
The paper handed over by Zhou Xiao left Liao Hai with only two words in his mind - I don't understand!
yes! Don't you understand?
If Zhou Xiao wants to publish some simple papers, even those of low quality, there is no problem.
However, Liao Hai thought that what he was reading was not a paper, but something very flighty and rootless.
The most academic taboo cannot be traced back, and the new theory is not supported by the old theory.
Zhou Xiao's paper goes far beyond Liao Hai's phenomenon. Liao Hai can even see how people in bioscience will look when they see such a magical paper.
Liao Hai was very polite to Zhou Xiao. He said, "Xiao Zhou, I don't know who wrote this paper, but it's obvious that the data cited in this paper is insufficient, and the content... Content..."
Of course, the basis is insufficient, because there is no reference basis before the experiment of origin science and technology, and it is impossible to quote any referential experiment at all.
Liao Hai even suggested to Zhou Xiao, "if it's for the company's rating, I have several topics that can be done here. Look at whether the biological laboratory of origin technology meets the relevant standards. I can apply to the school for these topics. Let's cooperate with the school and enterprises to complete the experiment. We'll write the paper and publish it in the name of your company."
Jiangcheng Institute of technology trains a lot of talents, but there are few well-known talents. There are fewer successful entrepreneurs like Zhou Xiao and get hundreds of millions of meters of knife financing. The school hopes to cooperate with Zhou Xiao very much, but Zhou Xiao can't take this paper.
Zhou Xiao insists on his opinion that the paper must be published. If the school can't find a way to help publish it, Zhou Xiao will find another way.
In view of the reason why Jiangcheng University of technology may have to cooperate with Yuanyuan science and technology in the future, Liao Hai agreed to publish Zhou Xiao's paper, but there is no guarantee that it must be bioscience.
"Xiao Zhou, the teacher keeps this in mind. Although I can't guarantee that Life Science publishes this paper, it must be a Chinese core journal."
With Liao Hai's words, Zhou Xiao was more relieved.
But a week later, Zhou Xiao knew it was too early to rest assured.
Jiangcheng Institute of technology will give Zhou Xiao face.
However, with the increasingly standardized academic today, it is impossible for any core journal to publish papers that are not papers at will.
Finally, Zhou Xiao got the so-called paper publication journal.
Zhou Xiao's papers are adopted in Bioscience and medical technology, a class C paper journal whose name is unknown. Most of the papers in this journal are not included in CSSCI, but are included in the overview of key Chinese core journals.
Jiangcheng University of technology has kept its promise, but the publication of such papers is tantamount to non publication.
This week, Zhou Xiao has never heard of the papers on journals with names. They are basically written in the format of papers. They can be published with money. They are meaningless in the academic community, and they can't even make a bubble.
Generally, major universities can't save face and order a little. After such a magazine is sent to the school, teachers and students basically won't read it. Instead, they directly throw the magazine into the carton and sell waste products after collecting enough boxes.
With the requirements of graduate students for papers included by SSCI and CSSCI, the living space of third rate academic journals such as Bioscience and medical technology is becoming narrower and narrower.
Zhou Xiao never thought that such an important paper had been published in the third rate journal Bioscience and medical technology, and had not been included in the overview of key Chinese core journals.
This means that after the paper is published, it has no influence, and relevant institutions will not agree to your clinical experiment because of your junk paper.
When Zhou Xiao put Bioscience and medical technology on the table of the laboratory, the five member group looked at each other. Everyone had published papers. Of course, they knew that Bioscience and medical technology had no gold content at all. It was a junk magazine serving for the evaluation of junior and intermediate professional titles.